Nano pharmaceuticals market analysis| Coherent Market Insights

1
Coherent Marketing Insights

• Market Research Business Consulting Services

• https//www.coherentmarketinsights.com/

• Covid-19 Impact Tracker

2

• NANO-PHARMACEUTICALS MARKET ANALYSIS
• Nanopharmaceuticals Market, by Carrier Type
  (Liposomes, Polymer, Nanocrystals, Inorganic,
  Protein, and Others), by Application (Oncology,
  Neurology, Anti-inflammatory, Anti-infective,
  Cardiovascular, and Others), by End User
  (Hospital Pharmacies, Retail Pharmacies, and
  Online Pharmacies), and by Region (North America,
  Latin America, Europe, Asia Pacific, Middle East,
  and Africa) - Global industry Insights and
  Forecast till 2026
• Nanopharmaceuticals are novel medicine with
  particle size less than 1 micron, which work on
  the principle of nanotechnology.
  Nanopharmaceuticals are widely used in drug
  delivery as a carrier for therapeutic compound or
  as a therapeutic compound. Nanopharmaceuticals
  are designed to target particular cells, tissue
  or a specific organ.

3

• Market Dynamics
• Increasing prevalence of cardiovascular diseases,
  cancer, and infectious diseases are major factors
  driving nanopharmaceuticals market growth. The
  World Health Organization, factsheet September
  2018, estimated around 10 million cases of
  tuberculosis and around 1.6 million deaths from
  the disease in 2017. Moreover, advantages of
  nanopharmaceuticals over macroscopic level
  medicines is expected to boost the market growth.
  Nanopharmaceuticals can pass the blood brain
  barrier and can access the remote areas of brain
  as well as low solubility of the compound can be
  developed for enhancing its characteristics.

4

• Key features of the study
• This report provides in-depth analysis of the
  nanopharmaceuticals market and provides market
  size (US million) and Compound Annual Growth
  Rate (CAGR ) for the forecast period (2018
  2026), considering 2017 as the base year
• It elucidates potential revenue opportunities
  across different segments and explains attractive
  investment proposition matrices for this market
• This study also provides key insights about
  market drivers, restraints, opportunities, new
  product launches or approval, market trends,
  regional outlook, and competitive strategy
  adopted by key players
• It profiles key players in the global
  nanopharmaceuticals market based on the following
  parameters company overview, financial
  performance, product portfolio, market presence,
  distribution strategies, key developments,
  strategies, and future plans
• Key companies covered as a part of this study
  include, Abbott, GlaxoSmithKline and plc., Eli
  Lilly and Company, Astrazeneca plc., Novavax,
  Inc., Stryker Corporation, OSI Pharmaceuticals,
  Kadmon Pharmaceuticals, Samyang Biopharm,
  Mitsubishi Tanabe Pharma Corporation, Kaken
  Pharmaceutical, Selecta Biosciences, Par
  Pharmaceutical, Cerulean Pharma Inc., Navidea
  Biopharmaceuticals, Inc., AbbVie Inc., AMAG
  Pharmaceuticals, Amgen Inc., Astellas Pharma
  Inc., Celgene Corporation, Gilead Sciences, Inc.,
  JOHNSON JOHNSON, Merck Co., Inc., Novartis
  AG, Pfizer, Inc., Hoffmann-La Roche AG, Sanofi
  S.A, Shire Plc., and Teva Pharmaceuticals
  Industries Limited.

5

• Detailed Segmentation
• Global Nanopharmaceuticals Market, By Carrier
• Liposomes
• Polymer
• Nanocrystals
• Inorganic
• Protein
• Others
• Global Nanopharmaceuticals Market, By
  Application
• Oncology
• Neurology
• Anti-inflammatory
• Anti-infective
• Cardiovascular
• Others

6
Figure 1. Global Nanopharmaceuticals Market Value
(US Mn), by Region, 2017

7
Figure 2. Global Nanopharmaceuticals Market Share
(), by Carrier Type, 2018 and 2026
8
Rising prevalence of chronic diseases in North
America is expected to drive the North America
nanopharmaceuticals market growth

• North America holds dominant position in the
  global nanopharmaceuticals market, owing to
  increasing research and development activities in
  application of nanotechnology in pharmaceuticals
  and rising prevalence of chronic disorders.
  According to the Centers for Disease Control and
  Prevention (CDC) factsheet, around 6 in 10 adults
  are diagnosed with chronic diseases and 4 in 10
  adults have two chronic diseases in the U.S.
  According to the same source, chronic diseases
  account for around 75 of healthcare spending in
  the U.S.
• Key manufacturers in the region focuses on
  developing and innovating new drugs for meeting
  the needs of patients, which is expected to
  bolster the market growth over the forecast
  period. For instance, in October 2012, Celgene
  Corporation, a U.S.-based company, received
  approval from the U.S. Food and Drug
  Administration (FDA) for Abraxane (paclitaxel
  protein-bound particles for injectable
  suspension), which is used for first-line
  treatment of advanced non-small cell lung cancer.
• Moreover, key players in the market are focused
  on receiving the U.S. Food and Drug
  Administration (FDA) approval for novel products
  to treat patients. For instance, in May 2017,
  NovoNodisk received Food and Drug Administration
  (FDA) approval for glycopegylated Rebinyn, which
  is used to control bleeding and bleeding
  management in patients diagnosed with hemophilia
  B.

9

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Referance https//www.coherentmarketinsights.com/
  market-insight/nanopharmaceuticals-market-2485

10
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions. We are headquartered
  in India, having office at global financial
  capital in the U.S. Our client base includes
  players from across all business verticals in
  over 150 countries worldwide.
• What We ProvideCustomized Market Research
  AnalysisIndustry Analysis ServicesBusiness
  Consulting ServicesLong Term Engagement
  ModelCountry Specific Analysis

11
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt. LTD.Coherent
  Market Insights 1001 4th Ave, 3200 Seattle, WA
  98154, U.S.Phone [phone]
• Email sales_at_coherentmarketinsights.com

12
Thank You

• Kindly Follow CMI Social Media Profiles for the
  latest Company Updates.
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/